H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on AquaBounty Technologies (AQB) today and set a price target of $4.50. The company’s shares closed last Tuesday at $3.92.
According to TipRanks.com, Dede has 0 stars on 0-5 stars ranking scale with an average return of -8.6% and a 35.7% success rate. Dede covers the Technology sector, focusing on stocks such as WISeKey International Holding, Magic Software Enterprises, and POET Technologies.
AquaBounty Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $4.75.
See today’s analyst top recommended stocks >>
Based on AquaBounty Technologies’ latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $2,950 and GAAP net loss of $3.52 million. In comparison, last year the company earned revenue of $42.49K and had a GAAP net loss of $4.03 million.
Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AQB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AquaBounty Technologies, Inc. is a biotechnology company, which focuses on the enhancement and improvement of the productivity in commercial aquaculture. It uses genetic manipulation and other molecular biologic techniques in order to improve the quality and yield of fish stocks. The company was founded by Elliot Z. Entis and Garth L. Fletcher on December 17, 1991 and is headquartered in Maynard, MA.
